Xerox Holdings Reaffirms FY24 Revenues Outlook - Update
(RTTNews) - While reporting financial results for the first quarter on Tuesday, workplace technology company Xerox Holdings Corp. (XRX) said it continues to expect revenues for the full-year 2024 to be decline 3 to 5 percent in constant currency and adjusted operating margin of at least 7.5 percent.
On average, four analysts polled by Thomson Reuters expect a revenue decline of 4.3 percent to $6.59 billion for the year.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
Xerox Holdings Expects FY23 Revenues To Decline In Constant Currency - Update
While reporting financial results for the third quarter on Tuesday, workplace technology company Xerox Holdings Corp. (XRX) said it expects revenues for the full-year 2023 to be flat to down low-single-digits in constant currency.
RTTNews
|
vor 210 Tagen
Xerox Holdings Confirms Steven Bandrowczak As CEO
Xerox Holdings Corp. (XRX) announced Wednesday that its Board of Directors has appointed Steven Bandrowczak as Chief Executive Officer.
RTTNews
|
vor 657 Tagen
TELUS To Invest $24 Bln To Enhance Network In Ontario Over Next Five Years
Telecom company TELUS Corp. (TU) announced Tuesday it will invest $24 billion to significantly expand and improve its network infrastructure and operations across Ontario over the next five years.
RTTNews
|
vor 5Std 26 Minuten
CareCloud Promotes Crystal Williams To COO
CareCloud, Inc. (CCLD), a healthcare technology solutions provider, announced Tuesday the promotion of Crystal Williams as its new chief operating officer with the goal of further streamlining operations and supporting the Company's achievement of its profitability and free cash flow objectives.
RTTNews
|
vor 6Std 0 Minuten
Lowe's Q1 Earnings Down, But Beat Market; Backs FY24 View; Stock Up
Home improvement major Lowe's Companies, Inc. on Tuesday maintained its fiscal 2024 earnings and sales outlook after reporting weak results in its first quarter. However, the quarterly earnings per share were above market estimates. In pre-market activity on the NYSE, Lowe's shares were gaining around 3.1 percent...
RTTNews
|
vor 6Std 0 Minuten
Alvotech Partners Dr. Reddy's To Bring AVT03 Biosimilar To Prolia & Xgeva To U.S., Europe, And U.K
Biotech company Alvotech (ALVO) and Dr. Reddy's Laboratories SA, wholly-owned subsidiary of Dr. Reddy's Laboratories Ltd. (RDY), announced Tuesday that the companies have entered into a license and supply agreement for the commercialization of AVT03, Alvotech's biosimilar candidate to Prolia and Xgeva (denosumab).
RTTNews
|
vor 6Std 15 Minuten
Bay Street Likely To Open Lower; Inflation Data In Focus
Canadian shares may open with a negative bias Tuesday morning, tracking weak global markets, and lower commodity prices. Canadian inflation data is likely to make a significant impact on sentiment.
RTTNews
|
vor 6Std 19 Minuten
Citius Pharma Announce Positive Topline Results For Pivotal Phase 3 Clinical Trial Of Mino-Lok
Biopharmaceutical company Citius Pharmaceuticals, Inc. (CTXR) announced Tuesday positive topline results of its pivotal Phase 3 clinical trial of Mino-Lok, a novel antibiotic lock solution designed to salvage catheters in patients with central line-associated infections (CLABSI) or catheter-related bloodstream infections (CRBSI).
RTTNews
|
vor 7Std 2 Minuten
